[S-8] Conduit Pharmaceuticals Inc. Employee Benefit Plan Registration

Rhea-AI Filing Summary

CDT Equity Inc. filed a Form S-8 to register an additional 2,000,000 shares of common stock for issuance under its Amended and Restated 2023 Stock Incentive Plan. The filing states the company changed its name to CDT Equity Inc. and effected 1-for-100 and 1-for-15 reverse stock splits; all share numbers reflect those splits. Prior registration statements had registered 7,665, 2,460 and 4,616 shares respectively. The filing incorporates recent SEC reports by reference.

Positive

• Registers an additional 2,000,000 shares available for issuance under the Amended and Restated 2023 Stock Incentive Plan.
• Plan approved by the board and stockholders, and the filing includes required exhibits and consents, enabling award grants to proceed.

Negative

• Up to 2,000,000 additional shares may be issued under the plan, which could increase the number of shares outstanding if awards are granted and vested.
• Reverse stock splits (1-for-100 and 1-for-15) were effected, requiring restatement of historical per-share figures and comparability adjustments.

Insights

Financial Analyst

TL;DR: Routine equity compensation registration; adds 2,000,000 shares to the employee plan pool, with share counts adjusted for reverse splits.

The registrant is registering an additional 2,000,000 shares for issuance under its Amended and Restated 2023 Stock Incentive Plan, reflecting board and stockholder approval referenced in the filing. The S-8 incorporates the companys recent SEC reports and prior S-8 filings that together show previously registered tranches of 7,665, 2,460 and 4,616 shares. The filing also confirms a corporate name change to CDT Equity Inc. and two reverse stock splits (1-for-100 and 1-for-15) with all share figures stated on a post-split basis. This is a procedural registration to enable equity awards rather than an operational or earnings disclosure.

Corporate Governance Expert

TL;DR: Governance housekeeping—stock incentive plan expansion documented and authorized; signatures and POA indicate appropriate corporate approvals.

The filing documents approval of the Amended and Restated 2023 Stock Incentive Plan by the board and stockholders and registers an additional 2,000,000 shares for issuance under that plan. The registration statement includes a power of attorney and is signed by the chief executive officer, chief financial officer and multiple directors, and it incorporates by reference the companys annual and quarterly reports and a proxy statement. Exhibits include the plan, option agreement forms and auditor and counsel consents. The filing is consistent with standard corporate governance processes for equity compensation administration.

As filed with the Securities and Exchange Commission on August 11, 2025

Registration No. 333-__________

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

CDT EQUITY INC.

(Exact name of Registrant as specified in its charter)

Delaware		87-3272543
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

4581 Tamiami Trail North, Suite 200 Naples, FL		34103
(Address of principal executive offices)		(Zip Code)

CDT Equity Inc. 2023 Amended and Restated Stock Incentive Plan

(Full title of the plan)

Andrew Regan

Chief Executive Officer

CDT Equity Inc.

4581 Tamiami Trail North, Suite 200

Naples, FL 34103

(Name and address of agent for service)

(646) 491-9132

(Telephone number, including area code, of agent for service)

Copies to:

Todd Mason, Esq.

Thompson Hine LLP

300 Madison Ave, 27th Floor

New York, NY 10017

(212) 344-5680

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐

EXPLANATORY NOTE

Effective August 5, 2025, Conduit Pharmaceuticals Inc. changed its name to CDT Equity Inc. (the “Registrant”).

On January 25, 2025, and May 19, 2025, the Registrant effected a 1-for-100 reverse stock split and a 1-for-15 reverse stock split of its issued and outstanding common stock, respectively (collectively, the “Reverse Stock Splits”). Unless otherwise indicated, all share numbers herein, including common stock registered hereunder and registered under prior registration statements, give effect to the Reverse Stock Splits.

This registration statement on Form S-8 registers an additional 2,000,000 shares of common stock of the Registrant that may be issuable under the CDT Equity Inc. Amended and Restated 2023 Stock Incentive Plan (as may be amended from time to time, the “2023 Plan” or the “Plan”), which was recently approved by the Registrant’s Board of Directors on July 8, 2025, and by the Registrant’s stockholders on August 5, 2025.

The Registrant previously registered (i) 7,665 shares of common stock available for issuance under the 2023 Plan on a registration statement on Form S-8, filed by the Registrant on December 1, 2023, File No. 333-275860, (ii) 2,460 shares of common stock available for issuance under the 2023 Plan pursuant to the Plan’s evergreen provision effective January 1, 2024, on a registration statement on Form S-8, filed by the Registrant on January 10, 2024, File No. 333-276461, and (iii) 4,616 additional shares of common stock for issuance under the 2023 Plan pursuant to the Plan’s evergreen provision effective January 1, 2025, on a registration statement on Form S-8, filed by the Registrant on February 6, 2025, File No. 333-284741 (such registration statements on Form S-8, the “Prior Registration Statements”). In accordance with General Instruction E of Form S-8, the contents of the Prior Registration Statements are hereby incorporated by reference in this registration statement. Only those items of Form S-8 containing new information not contained in the in the Prior Registration Statements are presented herein.

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

As permitted by the rules of the U.S. Securities and Exchange Commission (the “SEC”), this registration statement omits the information specified in Part I of Form S-8.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant with the SEC are incorporated by reference into this registration statement:

	(a)	The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 28, 2025.
	(b)	The Registrant’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, filed with the SEC on May 15, 2025.
	(c)	The Registrant’s Current Reports on Form 8-K (other than any portions thereof deemed furnished and not filed), filed with the SEC on January 14, 2025, January 23, 2025, February 11, 2025, February 19, 2025, March 6, 2025, April 1, 2025 (as amended on April 2, 2025), April 4, 2025, April 16, 2025, April 25, 2025, May 6, 2025, May 16, 2025, June 3, 2025, June 9, 2025, and August 8, 2025.
	(d)	The Registrant’s definitive proxy statement on Schedule 14A, as filed with the SEC on July 8, 2025.
	(e)	The description of the Registrant’s securities contained in the Registrant’s registration statement on Form 8-A, filed with the SEC on September 22, 2023 (File No. 001-41245), as well as any additional amendments or reports filed for the purpose of updating such description.
	(f)	All other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of Securities Exchange Act of 1934, as amended (the “Exchange Act”), (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) on or after the date of this registration statement and prior to the filing of a post-effective amendment to this registration statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this registration statement from the date of the filing of such reports and documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

Item 8. Exhibits.

Exhibit No.		Description
4.1		CDT Equity Inc. Amended and Restated 2023 Stock Incentive Plan (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 8, 2025, and incorporated herein by reference).
4.2		Specimen Common Stock Certificate of CDT Equity Inc. (filed as Exhibit 4.8 to the Registrant’s Amendment No. 3 to Registration Statement on Form S-4 (File No. 333-271903) filed on August 8, 2023, and incorporated herein by reference).
4.3		Form of Stock Option Agreement under the CDT Equity Inc. Amended and Restated 2023 Stock Incentive Plan (filed as Exhibit 10.17 to the Registrant’s Registration Statement on Form S-4 (File No. 333-271903) filed on May 12, 2023, and incorporated herein by reference).
5.1*		Opinion of Thompson Hine LLP.
23.1*		Consent of Marcum LLP, independent public accounting firm of CDT Equity Inc.
23.2*		Consent of Thompson Hine LLP (included in Exhibit 5.1 hereto).
24.1*		Power of Attorney (included on signature page).
107*		Filing Fee Table.

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Naples, State of Florida, on August 11, 2025.

	CDT EQUITY INC.
	By:	/s/ Andrew Regan
	Name:	Andrew Regan
	Title:	Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Andrew Regan and/or James Bligh, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the undersigned, thereunto duly authorized.

Signature		Title		Date
/s/ Andrew Regan		Chief Executive Officer and Director		August 11, 2025
Andrew Regan		(Principal Executive Officer)
/s/ James Bligh		Chief Financial Officer and Director		August 11, 2025
James Bligh		(Principal Financial Officer and Principal Accounting Officer)
/s/ Freda Lewis-Hall		Director and Chairperson of the Board of Directors		August 11, 2025
Freda Lewis-Hall
/s/ Chele Chiavacci Farley		Director		August 11, 2025
Chele Chiavacci Farley
/s/ Simon Fry		Director		August 11, 2025
Simon Fry

FAQ

What does the CDT (CDT) Form S-8 register?

The filing registers an additional 2,000,000 shares of common stock for issuance under the CDT Equity Inc. Amended and Restated 2023 Stock Incentive Plan.

How many shares were previously registered under the 2023 Plan?

Prior registration statements registered 7,665 shares, 2,460 shares (evergreen effective January 1, 2024) and 4,616 shares (evergreen effective January 1, 2025).

Did the company change its name to CDT Equity Inc.?

Yes. The filing states that the company changed its name to CDT Equity Inc.

Were reverse stock splits implemented by CDT?

Yes. The filing indicates the company effected a 1-for-100 reverse split and a 1-for-15 reverse split, and all share numbers in the filing reflect those splits.

Which documents are incorporated by reference into the registration statement?

The filing incorporates the registrants Annual Report for the fiscal year ended December 31, 2024, the Quarterly Report for the period ended March 31, 2025, various Current Reports, the definitive proxy statement and the Form 8-A description of the registrants securities.

Who signed the registration statement for CDT?

The registration statement is signed by Andrew Regan (Chief Executive Officer) and James Bligh (Chief Financial Officer), and is also signed by the chairperson and other directors listed in the filing.